Publication Date
10-1-2022
Abstract
BACKGROUND: No studies evaluated the role of
OBJECTIVES: To explore the association between
METHODS: Children SHA with high-titer inhibitors who received low-dose ITI therapy at least for 1 year were included in this study. Based on the risk of inhibitor development,
RESULTS: Of 104 children included, 101 had
CONCLUSIONS: Types of
Keywords
F8 mutation, high‐titer inhibitor, immune tolerance induction, low‐dose, predictor, severe hemophilia A
Comments
Supplementary Materials
PMID: 36313984